Expert Interview
Discussing AstraZeneca's Baxdrostat and the results from the BaxHTN Phase III trial of patients with uncontrolled or treatment resistant hypertension
Ticker(s): AZN, MLYSInstitution: Thomas Jefferson University Hospitals
- Cardiologist based in Philadelphia, Pennsylvania, affiliated with Thomas Jefferson University Hospitals–Jefferson Health and Penn Presbyterian Medical Center
- Actively manages approximately 150 patients with uncontrolled hypertension annually
- Clinical Assistant Professor at Sidney Kimmel Medical College with expertise in managing coronary artery disease, heart failure, and hypertension
Describe your background and practice setting
Added By: nick_adminHow many patients with uncontrolled hypertension do you currently manage?
Added By: nick_adminWhere would Baxdrostat fit into your treatment algorithm for uncontrolled hypertension?
Added By: nick_adminRank your excitement for Baxdrostat on a scale of 1-10
Added By: nick_adminCan you describe the standard of care for uncontrolled hypertension?
Added By: nick_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
